ClinicalTrials.Veeva

Menu

Visual Rehabilitation After Occipital Stroke

University of Rochester logo

University of Rochester

Status

Active, not recruiting

Conditions

Hemianopsia
Visual Field Defect, Peripheral
Visual Fields Hemianopsia
Stroke Hemorrhagic
Vision Loss Partial
Stroke, Ischemic
Peripheral Visual Field Defect
Quadrantanopsia
Occipital Lobe Infarct
Peripheral Visual Field Defect of Both Eyes
Hemianopia
Homonymous Hemianopia
Quadrantanopia
Homonymous Hemianopsia

Treatments

Device: Chronic Training in the blind field
Device: Subacute Training in the intact field
Device: Subacute Training in the blind field

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04798924
R01EY027314 (U.S. NIH Grant/Contract)
00005966

Details and patient eligibility

About

This research aims to examine changes in plastic potential of the visual system with time from stroke affecting primary visual cortex. We will measure structural and mechanistic aspects of progressive degeneration along the early visual pathways, correlating them with changes in visual performance, and in responsiveness to visual restoration training. This project will advance both scientific knowledge, as well as technical capability and clinical practices for restoring vision and quality of life for people suffering from cortical blindness.

Enrollment

60 estimated patients

Sex

All

Ages

21 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Residents of US and Canada
  • MRI and/or CT scans showing evidence of one-sided / unilateral stroke or stroke-like damage to the primary visual cortex or its immediate afferent white matter sustained less than 6-months prior to enrollment
  • Reliable visual field defects in both eyes as measured by Humphrey, Macular Integrity Assessment (MAIA), Goldmann, and/or equivalent perimetry. This deficit must be large enough to enclose a 5-deg diameter visual stimulus.
  • Ability to fixate on visual targets reliably for 1000ms (as demonstrated by visual fields, and verified in study participation)
  • Willing and safely able to undergo magnetic resonance imaging (MRI) scanning
  • Willing, able, and competent to provide informed consent
  • Fluent in written and spoken English
  • Cognitively able, responsible, and willing to complete daily visual training independently at home for several months.

Exclusion criteria

  • Past or present ocular disease interfering with vision
  • Best corrected visual acuity worse than 20/40 in either eye
  • Presence of damage to the dorsal Lateral Geniculate Nucleus, as shown on MRI/CT scans
  • Diffuse, whole brain degenerative processes
  • Brain damage deemed by study staff to potentially interfere with training ability or outcome measures
  • History of traumatic brain injury
  • Documented history of drug/alcohol abuse
  • Currently use of neuroactive medications which would impact training, as determined by PI
  • Cognitive or seizure disorders
  • One-sided attentional neglect
  • Inability to perform the visual training exercises as directed

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

Training in the blind field
Experimental group
Description:
Training in the blind field using specialized software
Treatment:
Device: Subacute Training in the blind field
Device: Chronic Training in the blind field
Training in the intact field
Experimental group
Description:
Training in the intact field using specialized software
Treatment:
Device: Subacute Training in the intact field
Device: Chronic Training in the blind field

Trial contacts and locations

1

Loading...

Central trial contact

Evan Burr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems